| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Announcements
|
|
|
1999
|
|
2 |
p. 231-232
2 p.
|
article
|
| 2 |
Announcements
|
|
|
1998
|
|
2 |
p. 261-262
2 p.
|
article
|
| 3 |
Announcements
|
|
|
1999
|
|
2 |
p. 231-232
|
article
|
| 4 |
Announcements
|
|
|
1997
|
|
2 |
p. 261-262
|
article
|
| 5 |
Announcements
|
|
|
1998
|
|
2 |
p. 261-262
|
article
|
| 6 |
Announcements
|
|
|
1997
|
|
2 |
p. 261-262
2 p.
|
article
|
| 7 |
A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids
|
Meibohm, Bernd
|
|
1999
|
|
2 |
p. 127-147
|
article
|
| 8 |
A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids
|
Bernd Meibohm
|
|
1999
|
|
2 |
p. 127-147
21 p.
|
article
|
| 9 |
Application of the Dispersion Model for Description of the Outflow Dilution Profiles of Noneliminated Reference Indicators in Rat Liver Perfusion Studies
|
Schwab, Andreas J.
|
|
1998
|
|
2 |
p. 163-181
|
article
|
| 10 |
Application of the Dispersion Model for Description of the Outflow Dilution Profiles of Noneliminated Reference Indicators in Rat Liver Perfusion Studies
|
Andreas J. Schwab
|
|
1998
|
|
2 |
p. 163-181
19 p.
|
article
|
| 11 |
A Recirculatory Model of the Pulmonary Uptake and Pharmacokinetics of Lidocaine Based on Analysis of Arterial and Mixed Venous Data from Dogs
|
Krejcie, Tom C.
|
|
1997
|
|
2 |
p. 169-190
|
article
|
| 12 |
A Recirculatory Model of the Pulmonary Uptake and Pharmacokinetics of Lidocaine Based on Analysis of Arterial and Mixed Venous Data from Dogs
|
Tom C. Krejcie
|
|
1997
|
|
2 |
p. 169-190
22 p.
|
article
|
| 13 |
Assumption Testing in Population Pharmacokinetic Models Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients
|
Mats O. Karlsson
|
|
1998
|
|
2 |
p. 207-246
40 p.
|
article
|
| 14 |
Assumption Testing in Population Pharmacokinetic Models: Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients
|
Karlsson, Mats O.
|
|
1998
|
|
2 |
p. 207-246
|
article
|
| 15 |
Bayesian Nonparametric Population Models: Formulation and Comparison with Likelihood Approaches
|
Wakefield, Jon
|
|
1997
|
|
2 |
p. 235-253
|
article
|
| 16 |
Bayesian Nonparametric Population Models Formulation and Comparison with Likelihood Approaches
|
Jon Wakefield
|
|
1997
|
|
2 |
p. 235-253
19 p.
|
article
|
| 17 |
Bayesian Population Pharmacokinetic and Pharmacodynamic Analyses Using Mixture Models
|
Rosner, Gary L.
|
|
1997
|
|
2 |
p. 209-233
|
article
|
| 18 |
Bayesian Population Pharmacokinetic and Pharmacodynamic Analyses Using Mixture Models
|
Gary L. Rosner
|
|
1997
|
|
2 |
p. 209-233
25 p.
|
article
|
| 19 |
Characterization of the Dose-Dependent Time of Peak Effect in Indirect Response Models
|
Majumdar, Anup
|
|
1998
|
|
2 |
p. 183-206
|
article
|
| 20 |
Characterization of the Dose-Dependent Time of Peak Effect in Indirect Response Models
|
Anup Majumdar
|
|
1998
|
|
2 |
p. 183-206
24 p.
|
article
|
| 21 |
Constructing a Prediction Interval for Time to Reach a Threshold Concentration Based on a Population Pharmacokinetic Analysis: An Application to Basiliximab in Renal Transplantation
|
Mentré, France
|
|
1999
|
|
2 |
p. 213-230
|
article
|
| 22 |
Construction of an Optimal Destructive Sampling Design for Noncompartmental AUC Estimation
|
Vandenhende, Francois
|
|
1999
|
|
2 |
p. 191-212
|
article
|
| 23 |
Construction of an Optimal Destructive Sampling Design for Noncompartmental AUC Estimation
|
Francois Vandenhende
|
|
1999
|
|
2 |
p. 191-212
22 p.
|
article
|
| 24 |
Do Plasma Concentrations Obtained from Early Arterial Blood Sampling Improve Pharmacokinetic/Pharmacodynamic Modeling?
|
Beaufort, Ton M.
|
|
1999
|
|
2 |
p. 173-190
|
article
|
| 25 |
Do Plasma Concentrations Obtained from Early Arterial Blood Sampling Improve Pharmacokinetic/Pharmacodynamic Modeling
|
Ton M. Beaufort
|
|
1999
|
|
2 |
p. 173-190
18 p.
|
article
|
| 26 |
Errors in Clearance Estimation After Bolus Injection and Arterial Sampling: Nonexistence of a Central Compartment
|
Weiss, Michael
|
|
1997
|
|
2 |
p. 255-260
|
article
|
| 27 |
Errors in Clearance Estimation After Bolus Injection and Arterial Sampling Nonexistence of a Central Compartment
|
Michael Weiss
|
|
1997
|
|
2 |
p. 255-260
6 p.
|
article
|
| 28 |
Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development: II. From Healthy Subjects to Phase 2 Dose Ranging in Patients
|
Cosson, Valérie F.
|
|
1999
|
|
2 |
p. 149-171
|
article
|
| 29 |
Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development II. From Healthy Subjects to Phase 2 Dose Ranging in Patients
|
Valérie F. Cosson
|
|
1999
|
|
2 |
p. 149-171
23 p.
|
article
|
| 30 |
Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling
|
Cosson, Valérie F.
|
|
1997
|
|
2 |
p. 149-167
|
article
|
| 31 |
Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I Interspecies Allometric Scaling
|
Valérie F. Cosson
|
|
1997
|
|
2 |
p. 149-167
19 p.
|
article
|
| 32 |
Pharmacokinetic Analysis of Mizolastine in Healthy Young Volunteers After Single Oral and Intravenous Doses: Noncompartmental Approach and Compartmental Modeling
|
Mesnil, Florence
|
|
1997
|
|
2 |
p. 125-147
|
article
|
| 33 |
Pharmacokinetic Analysis of Mizolastine in Healthy Young Volunteers After Single Oral and Intravenous Doses Noncompartmental Approach and Compartmental Modeling
|
Florence Mesnil
|
|
1997
|
|
2 |
p. 125-147
23 p.
|
article
|
| 34 |
Pharmacokinetic-Based Minibolus Delivery as an Alternative to Continuous Infusion for Drugs That Exhibit a Biophase Lag
|
Kern, Steven E.
|
|
1997
|
|
2 |
p. 191-208
|
article
|
| 35 |
Pharmacokinetic-Based Minibolus Delivery as an Alternative to Continuous Infusion for Drugs That Exhibit a Biophase Lag
|
Steven E. Kern
|
|
1997
|
|
2 |
p. 191-208
18 p.
|
article
|
| 36 |
Pitfalls in Pharmacokinetic Multicompartment Analysis
|
Earvin Liang
|
|
1998
|
|
2 |
p. 247-260
14 p.
|
article
|
| 37 |
Pitfalls in Pharmacokinetic Multicompartment Analysis
|
Liang, Earvin
|
|
1998
|
|
2 |
p. 247-260
|
article
|
| 38 |
Population Pharmacokinetic Analysis of Mizolastine and Validation from Sparse Data on Patients Using the Nonparametric Maximum Likelihood Method
|
Mesnil, Florence
|
|
1998
|
|
2 |
p. 133-161
|
article
|
| 39 |
Population Pharmacokinetic Analysis of Mizolastine and Validation from Sparse Data on Patients Using the Nonparametric Maximum Likelihood Method
|
Florence Mesnil
|
|
1998
|
|
2 |
p. 133-161
29 p.
|
article
|
Journal description